跳至主要内容
临床试验/NCT03187704
NCT03187704已完成不适用

Boston Puerto Rican Health Study - Project 4

Tufts University2 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2012年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
23
试验地点
2
主要终点
Blood biomarkers

研究概览

简要总结

The study is a blinded cross over test of in-home air filtration. Participants will have a window unit air filter (HEPA) installed that will filter for 3 weeks and do sham filtration for another 3 weeks. During the time that the filter is installed in the home a machine that measures particulate air pollution of the type that the filter is designed to remove will be installed. A survey will be administered, blood samples taken and blood pressure measured immediately prior to starting the filter, at 3 weeks when the filtration is changed from sham to real filtration or visa versa and at the end of the second three week period. All participants will be recruited from the Boston Puerto Rican Health Study cohort.

详细描述

Project 4 Protocol:

I. Aims and Hypotheses

H1: That in-home active HEPA filtration will reduce ultrafine particle (UFP) levels >70% compared to sham filtration. Further, that HEPA filtration will reduce all size classes of ultrafine particles equally well.

H2: That markers of cardiovascular health, including C-reactive protein, fibrinogen, IL-6 and tumor necrosis factor alpha receptor, will be lower after living with active HEPA filtration compared to sham filtration.

H3: In-home HEPA filtration will be seen by policy-makers as an effective policy option for reducing UFP exposure in near-highway residences.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Participants were blinded as to filtration and no filtration. The lab was blinded as to which samples were from filtration or no filtration periods.

入排标准

年龄范围
45 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant in the larger parent cohort of the BPRHS

排除标准

  • None since already enrolled in the cohort

结局指标

主要结局

Blood biomarkers

时间窗: 6 weeks

hsCRP, IL-6, TNFRII

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Doug Brugge

Professor

Tufts University

研究点 (2)

Loading locations...

相似试验

Boston Puerto Rican Health Study | 临床试验